SCHEMBL12912486

SCHEMBL12912486

Cc1ccc(-c2nc3ccccc3n2-c2ccc(-c3ccc4ccc5cccc6ccc3c4c56)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 3/20 0.48
▸ ESR2 Q92731 3/20 0.48
▸ GRIA1 P42261 1/20 0.47
▸ CACNG8 Q8WXS5 1/20 0.47
▸ CACNG2 Q9Y698 1/20 0.47
▸ ALDH1A1 P00352 7/20 0.46
▸ NPSR1 Q6W5P4 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ PTGS2 P35354 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ LMNA P02545 2/20 0.41
▸ TP53 P04637 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ SIRT2 Q8IXJ6 1/20 0.40
▸ SIRT1 Q96EB6 1/20 0.40
▸ HTT P42858 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ FLT3 P36888 1/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12912523 0.95 ESR2 (0.52) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL9976944 0.93 ESR1 (0.56) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL9976949 0.92 ESR1 (0.55) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL9976946 0.92 ESR1 (0.55) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL10041759 0.92 ESR1 (0.51) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL9976950 0.89 ESR2 (0.60) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL12912481 0.88 MAPK10 (0.47) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL11954062 0.88 RECQL (0.47) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL14363300 0.88 ESR1 (0.51) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL12912475 0.88 NLRP3 (0.47) ESR1ESR2GRIA1CACNG8CACNG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8945724-B2 Nitrogen-containing heterocyclic derivative and organic electroluminescent device using the same IDEMITSU KOSAN CO., LTD. (JP) 2015-02-03 — — US disclosed
US-8945724-B2 Nitrogen-containing heterocyclic derivative and organic electroluminescent device using the same IDEMITSU KOSAN CO., LTD. (JP) 2015-02-03 — — US disclosed
US-20110012092-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2011-01-20 — — US disclosed
US-20110012092-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2011-01-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110012092-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME NUDC, TYR, NUDT1 ESR1 563/4885ESR2 1585/4885GRIA1 2587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback